Evidence hub

Rheumatoid Arthritis: cell-therapy evidence by therapy class

Across every stem-cell intervention, ClinicalTrials.gov holds 44 registered records for Rheumatoid Arthritis — 8 recruiting, 2 at Phase 3 or 4, in 27 countries. Snapshot 2026-08-29.

Medical review statusMedically reviewedReviewed by: Stem Plus medical teamReviewed on: 2026-08-29Last evidence update: 2026-08-29Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

The condition, and why cells are proposed

Rheumatoid arthritis is autoimmune synovial inflammation causing joint erosion. Mesenchymal cells are studied for immunomodulation, generally in disease refractory to conventional and biologic therapy. As with psoriasis, effective established treatments define the comparison — the question is not whether cells do something, but whether they beat what already works.

Therapy classes side by side

Therapy classRegisteredRecruitingPhase 3/4Countries
MSC222111
HSCT112112
exosomes4202
PRP5112

Counts come from separate registry queries per class; a study testing two interventions can appear in more than one row, so rows do not sum to the all-interventions total.

Geography of the research

United States accounts for about 41% of country mentions among sampled studies; 27 countries host at least one site.

CountryStudies with a site there
United States16
China6
South Korea4
Iran2
Denmark2
Germany2
Poland2
Spain2

The largest registered studies

Sorted by planned enrolment — size is not quality, but a 300-participant trial can answer questions a 12-participant series cannot.

StudyPhaseStatusPlanned nLead sponsorStart
NCT02639936 — New Generation IGRA in Immunocompromised Individualsn/aCompleted2,663Tuberculosis Network European Trialsgroup2015-12
NCT02327884 — Characterization of Diseases With Salivary Gland Involvementn/aRecruiting1,150National Institute of Dental and Craniofacial Research (NIDC2015-04-03
NCT04449224 — Comparative Effectiveness of Targeted Therapy in RA Patientsn/aUnknown506Hanyang University2020-04-27
NCT01978639 — Injections of FloGraft Therapy, Autologous Stem Cells, or Platelet Rich Plasma for the Treatment of Degenerative Joint Painn/aUnknown300Arizona Pain Specialists2014-01
NCT03798028 — The Safety and Effects of Mesenchymal Stem Cell (MSCs) in the Treatment of Rheumatoid Arthritisn/aUnknown250Xijing Hospital2017-12-26
NCT01547091 — Safety and Efficacy Study of Umbilical Cord-Derived Mesenchymal Stem Cells for Rheumatoid ArthritisPhase 1, Phase 2Unknown200Alliancells Bioscience Corporation Limited2013-04

Most recently registered

StudyPhaseStatusPlanned nLead sponsorStart
NCT03828344 — Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritisn/aNot Yet Recruitingn/aBaylx Inc.2026-12-01
NCT07301164 — Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseasesn/aNot Yet Recruitingn/aPeking University Third Hospital2025-12-11
NCT07290946 — Repeated Mesenchymal Stem Cell Therapy for Radiation-Induced Hyposalivation and Xerostomia in Head and Neck Cancer Survivorsn/aNot Yet Recruitingn/aChristian von Buchwald2025-12
NCT06947746 — HiSCs in the Treatment of Rheumatoid Arthritisn/aRecruitingn/aShanghai Changzheng Hospital2025-05-01
NCT06888973 — Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseasesn/aEnrolling By Invitationn/aNational Institute of Blood and Marrow Transplant (NIBMT), P2025-02-01

Reading this honestly

None of these numbers say the therapy works. They say how much organised research exists and how far along it is; effect sizes live in published results, not registry entries. For Rheumatoid Arthritis specifically, the practical question is which registered study — if any — matches the product a provider is offering, and what its outcome measures actually are.

Frequently asked

How many stem-cell trials exist for Rheumatoid Arthritis?

44 registered records mention a stem-cell intervention for this condition (2026-08-29 snapshot), of which 8 were recruiting.

Which therapy class is furthest along for Rheumatoid Arthritis?

Ranked by Phase 3/4 records: MSC (1), HSCT (1), PRP (1), exosomes (0).

Does a recruiting trial mean I can be treated?

No. Trials have eligibility criteria, and joining one is not the same as buying a treatment. Paying a clinic for an unproven intervention outside a registered study gives you neither the protections nor the data collection of a trial.

Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.

Explore all sections · Data & downloads

Download the query data

Download CSV · Download JSON

Query totals are full API matches; status, phase and country counts describe the first up to 400 returned records per query. Query classes overlap and must not be summed as unique trials. Counts are not treatment outcomes. Snapshot: 2026-08-29. Methods and field definitions.